Features | Partner Sites | Information | LinkXpress
Sign In
GLOBETECH PUBLISHING
JIB
GLOBETECH PUBLISHING

New Cell Analysis System Boasts Fully Automated Reading and Imaging Features

By BiotechDaily International staff writers
Posted on 02 May 2013
Image: The BioTek Cytation3 imaging reader - Quantitative and Qualitative Data for the Total Cell Picture (Photo courtesy of BioTek).
Image: The BioTek Cytation3 imaging reader - Quantitative and Qualitative Data for the Total Cell Picture (Photo courtesy of BioTek).
A powerful new cell analysis system enables simultaneous detection and microscopic analysis of samples in microplates or microscope slices while automatically controlling temperature, shaking, and gas flow.

The new Cytation3 Cell Imagining Multi-Mode Reader is a product of BioTek (Winooski, VT, USA), a leader in the design, manufacture, and sale of microplate instrumentation and software.

Cytation3 is a cell imaging multimode reader that combines automated digital microscopy and conventional microplate detection compatible with microplates with from 6 to 384 wells and microscope slides. An optional BioStack Microplate Stacker provides increased throughput and walkaway automation for up to 50 standard microplates. The multimode microplate detection system features Biotek's patented Hybrid Technology.

The Cytation3's unique patent pending design provides rich phenotypic cellular information with well-based quantitative data. The system incorporates both high sensitivity filter-based and flexible monochromator based optics for versatility and performance. The automated digital fluorescence microscope features bright field imaging and color switching through onboard filter cubes. Red (Texas Red), green (GFP) and blue (DAPI) cubes are standard, with a fourth position available. Automated XY stage, autofocus, autoexposure, and software features increase image capture throughput, cell counting, and other tasks. Onboard objectives in a magnification range from two to 20 times allow the researcher to view an entire microplate well or to zoom in on a single cell.

Augmenting its imaging and reading capabilities, the Cytation3 offers uniform temperature control to 45 °C, variable shaking modes, and carbon dioxide and oxygen gas regulation for live-cell assays. The integrated Gen5 Data Analysis Software is simple and intuitive to use, and enables the operator to control the reader, automate the entire process, and produce publication-ready reports from the data obtained.

Related Links:
BioTek



comments powered by Disqus

Channels

Genomics/Proteomics

view channel
Image: To adhere to catheters and start urinary tract infections, bacteria extend microscopic fibers with sticky proteins at their ends. Researchers have developed a vaccine that blocks the EbpA protein, visible as a white bulge above, and stops infections in mice (Photo courtesy of Dr. John Heuser, Washington University School of Medicine).

Blocking Binding of Bacteria to Fibrinogen Prevents Biofilm Formation and Catheter-Associated Bladder Infection in Mice

A team of molecular microbiologists has identified and targeted a critical step in biofilm formation and developed a vaccine that prevents catheter-associated urinary tract infections in mice.... Read more

Drug Discovery

view channel
Image: S-649266 has more robust antibacterial activity than established antibiotics against multidrug-resistant bacteria (Photo courtesy of Shionogi).

Novel Antibiotic Shows Potential for Broad Range of Infections

The emergence of bacterial resistance to known antibacterial agents is becoming a major challenge in treating the infection caused by multi drug resistant (MDR) bacteria. In order to treat bacterial... Read more

Business

view channel

Collaboration of Mayo Clinic and IBM Cognitive Computer Devised to Improve Clinical Trial Research

The Mayo Clinic (Rochester, MN, USA) and IBM (Armonk, NY, USA) recently announced plans to pilot Watson, the IBM cognitive computer, to match patients more rapidly with suitable clinical trials. A proof-of-concept phase is currently ongoing, with the intent to introduce it into clinical use in early 2015.... Read more
 
Copyright © 2000-2014 Globetech Media. All rights reserved.